Announced encouraging preliminary safety and efficacy data across all three RAS-pathway inhibitor programsAnnounced publication in Cancer ...
New research from Cold Spring Harbor Laboratory shows that blocking the protein PTP1B in mouse models of Alzheimer’s disease reactivates microglia, the brain’s immune cells, to clear amyloid-β plaques ...
New research underscores that age-related muscle loss can begin in the 30s, but just two weekly resistance training sessions combined with adequate protein can preserve muscle mass and function.
TOS-358 is a covalent, pan-mutant, a-selective PI3K inhibitor designed to address key limitations of existing PI3Ka therapies which include ...
TOS-358 is a covalent, pan-mutant, a-selective PI3K inhibitor designed to address key limitations of existing PI3Ka therapies which include limited mutation coverage and poor tolerability First ...
Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect ...
Traditionally seen as passive support cells, astrocytes are activated under various pathological conditions. Research of reactive astrocyte in the context ...
Background Hepatocellular carcinoma (HCC), one of the most prevalent cancers worldwide, has a high mortality owing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results